Simultaneous Platelet P2Y12 and P2Y1 ADP Receptor Blockade: Are Two Better Than One?

Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):427-8. doi: 10.1161/ATVBAHA.115.307097.
No abstract available

Keywords: Editorial; acute coronary syndrome; blood platelets; pharmacology; platelet aggregation inhibitors; thrombosis.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Blood Platelets / drug effects*
  • Coronary Thrombosis / drug therapy*
  • Dinucleoside Phosphates / pharmacology*
  • Female
  • Fibrinolytic Agents / pharmacology*
  • Humans
  • Male
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / pharmacology*
  • Purinergic P2Y Receptor Antagonists / pharmacology*
  • Receptors, Purinergic P2Y1 / drug effects*
  • Receptors, Purinergic P2Y12 / drug effects*

Substances

  • Dinucleoside Phosphates
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Receptors, Purinergic P2Y1
  • Receptors, Purinergic P2Y12